West Nile Virus In Focus As Second Diagnostic Kit Gains Clearance
This article was originally published in The Gray Sheet
Executive Summary
Focus Technologies, Inc. expects the inclusion of both IgG and IgM markers in its West Nile Virus ELISA diagnostic kit will compensate for its second-comer status in the WNV diagnostics race
You may also be interested in...
West Nile Virus: FDA Clears PanBio Test, Canada Okays Roche Blood Screen
The de novo 510(k) route pursued by PanBio for its Capture West Nile virus clinical lab test could set a precedent for expedited approvals of diagnostics to detect emerging diseases
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.